BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 24449964)

  • 21. Recent studies with EB virus.
    Epstein MA
    Yale J Biol Med; 1975 Nov; 48(5):431-7. PubMed ID: 174330
    [No Abstract]   [Full Text] [Related]  

  • 22. [Epstein-Barr virus-associated diseases--from infectious mononucleosis to malignant neoplasms].
    Kuroda M; Imai S
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():222-8. PubMed ID: 12722218
    [No Abstract]   [Full Text] [Related]  

  • 23. [New developments in the management of nasopharyngeal carcinoma].
    Blanchard P; Nguyen F; Moya-Plana A; Pignon JP; Even C; Bidault F; Temam S; Ruffier A; Tao Y
    Cancer Radiother; 2018 Oct; 22(6-7):492-495. PubMed ID: 30087054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Chan AT; Felip E;
    Ann Oncol; 2009 May; 20 Suppl 4():123-5. PubMed ID: 19454431
    [No Abstract]   [Full Text] [Related]  

  • 25. Biomarker discovery of nasopharyngeal carcinoma by proteomics.
    Xiao L; Xiao T; Wang ZM; Cho WC; Xiao ZQ
    Expert Rev Proteomics; 2014 Apr; 11(2):215-25. PubMed ID: 24611579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis and therapy of dermatomyositis associated with nasopharyngeal carcinoma and literature review].
    Gao S; Zhang G; Xie K
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 26(6):282-3. PubMed ID: 22675941
    [No Abstract]   [Full Text] [Related]  

  • 27. Modern treatment for nasopharyngeal carcinoma: current status and prospects.
    Rottey S; Madani I; Deron P; Van Belle S
    Curr Opin Oncol; 2011 May; 23(3):254-8. PubMed ID: 21330921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus-targeted immunotherapy for nasopharyngeal carcinoma.
    Masmoudi A; Toumi N; Khanfir A; Kallel-Slimi L; Daoud J; Karray H; Frikha M
    Cancer Treat Rev; 2007 Oct; 33(6):499-505. PubMed ID: 17544585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasopharyngeal carcinoma and Epstein-Barr virus--associated serologic markers.
    Tam JS; Murray HG
    Ear Nose Throat J; 1990 Apr; 69(4):261-7. PubMed ID: 2161732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs: potential diagnostic markers and therapeutic targets for EBV-associated nasopharyngeal carcinoma.
    He ML; Luo MX; Lin MC; Kung HF
    Biochim Biophys Acta; 2012 Jan; 1825(1):1-10. PubMed ID: 21958739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment approaches to nasopharyngeal carcinoma: a review.
    Caponigro F; Longo F; Ionna F; Perri F
    Anticancer Drugs; 2010 Jun; 21(5):471-7. PubMed ID: 20124988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary nasopharyngeal adenocarcinoma: a review.
    Xu T; Li ZM; Gu MF; Wei WH; Zhang GY; Wu QL; Su Y; Hu WH
    Asia Pac J Clin Oncol; 2012 Jun; 8(2):123-31. PubMed ID: 22524571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The EB virus.
    Epstein MA; Achong BG
    Annu Rev Microbiol; 1973; 27():413-36. PubMed ID: 4356531
    [No Abstract]   [Full Text] [Related]  

  • 34. Epstein-Barr virus serology in early detection and screening of nasopharyngeal carcinoma.
    Ng MH; Chan KH; Ng SP; Zong YS
    Ai Zheng; 2006 Feb; 25(2):250-6. PubMed ID: 16480597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer of the nasopharynx: its clinical course and management.
    Wang CC; Schulz MD
    Geriatrics; 1965 Oct; 20(10):864-70. PubMed ID: 5319418
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnostic evaluation of nasopharyngeal carcinoma: role of Epstein-Barr virus].
    Plaza G; Fogué L; Martínez San Millán J; Martínez Vidal A; Bellas C
    An Otorrinolaringol Ibero Am; 2002; 29(1):71-91. PubMed ID: 11962004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic review on Epstein-Barr virus (EBV) DNA in diagnosis of nasopharyngeal carcinoma in Asian populations.
    Han BL; Xu XY; Zhang CZ; Wu JJ; Han CF; Wang H; Wang X; Wang GS; Yang SJ; Xie Y
    Asian Pac J Cancer Prev; 2012; 13(6):2577-81. PubMed ID: 22938423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Research progress of the relationship between p53 and nasopharyngeal carcinomas].
    Hu W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):592-4. PubMed ID: 16137056
    [No Abstract]   [Full Text] [Related]  

  • 39. Individualized treatment in stage IVC nasopharyngeal carcinoma.
    Chan OS; Ngan RK
    Oral Oncol; 2014 Sep; 50(9):791-7. PubMed ID: 24518920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The diagnosis of nasopharyngeal carcinoma (author's transl)].
    Arnold W; Nakazima A; Wang YB; Vosteen KH; Brunner H; Göbel U
    HNO; 1980 Aug; 28(8):247-60. PubMed ID: 6254933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.